Hepatectomy: Preoperative analysis of hepatic function and postoperative liver failure

Digestive Surgery

Volumn 15, Issue 1, 1998, Pages 1-11

  Zimmermann, Heinz ^a   Reichen, Jürg ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Department of Cinical Pharmacology ^*  (Switzerland)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver function tests; Liver metastasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMINOPHENAZONE; BILE ACID; BILIRUBIN; LIVER ENZYME;

ALBUMIN BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BREATH ANALYSIS; ENZYME BLOOD LEVEL; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER PARENCHYMA; LIVER RESECTION; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; REVIEW;

BIOLOGICAL MARKERS; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TESTS; PREOPERATIVE CARE;

EID: 0031984766     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018578     Document Type: Review

References (103)

1. Elias D, Lasser P, Rougier P, Ducreux M, Bognel C, Roche A: Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995;180:213-219.
2. Bismuth H, Houssin D, Ornowski J, Meriggi F: Liver resections in cirrhotic patients: A western experience. World J Surg 1986;10:311-317.
3. Didolkar MS, Fitzpatrick JL, Elias EG, Whitley N, Keramati B, Suter CM, et al: Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989;169:17-26.
4. Capussotti L, Borgonovo G, Bouzari H, Smadja C, Grange D, Franco D: Results of major hepatectomy for large primary liver cancer in patients with cirrhosis. Br J Surg 1994;81:427-431.
5. Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, et al: Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg 1993;17:250-255.
6. Detroz B, Sugarbaker PH, Knol JA, Petrelli N, Hughes KS: Causes of death in patients undergoing liver surgery. Cancer Treat Res 1994; 69:241-257.
7. Chou FF, Sheen Chen SM, Chen CL, Chen YS, Chen MJ: Prognostic factors after hepatectomy for hepaptocellular carcinoma. Heptaogastroenterology 1994;41:419-423.
8. Foster JH: Surgical treatment of metastatic liver tumors. Hepatogastroenterology 1990;37: 182-187.
9. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al: Surgery for small liver cancers. Semin Surg Oncol 1993; 9:298-304.
10. The Liver Cancer Study Group of Japan: Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994;74: 2772-2780.
11. Fan ST, Lai EC, Lo CM, Ng IO, Wong J: Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995;130:198-203.
12. Zimmermann H, Reichen J: Assessment of liver function in the surgical patient; in Blumgart LH (ed): Surgery of the Liver and Biliary Tract, ed 2. New York, Churchill Livingstone, 1993, pp 41-64.
13. Gavelli A, Ghiglione B, Huguet C: Risk factors of hepatectomies: Results of a multivariate study. Apropos of 113 cases. Ann Chir 1993; 47:586-591.
14. Sizman JV, Greene PS: Perioperative predictors of morbidity following hepatic resection for neoplasm: A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 1994;219:13-17.
15. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T: Changes in serum amylase level following hepatic resection in chronic liver disease. Arch Surg 1994;129:634-638.
16. Ekberg H, Tranberg KG, Andersson R, Jeppsson B, Bengmark S: Major liver resection: Perioperative course and management. Surgery 1986;100:1-8.
17. Ohkubo H, Okuda K, Iida S, Ohnishi K, Ikawa S, Makino I: Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. Gastroenterology 1984;86:514-520.
18. Mannes GA, Stellaard F, Paumgartner G: Increased serum bile acids in cirrhosis with normal transaminases. Digestion 1982;25:217-221.
19. Mannes GA, Thieme C, Stellaard F, Wang T, Sauerbruch T, Paumgartner G: Prognostic significance of serum bile acids in cirrhosis. Hepatology 1986;6:50-53.
20. Baron DN: A critical look at the value of biochemical liver function tests with special reference to discriminant function analysis. Ann Clin Biochem 1970;7:100-112.
21. Winkel P, Ramsoe K, Lyngbye J, Tygstrup N: Diagnostic value of routine liver tests. Clin Chem 1975;21:71-75.
22. Solberg HE, Skrede S, Blomhoff JP: Diagnosis of liver disease by laboratory results and discriminant analysis: Identification of best combination of laboratory tests. Scand J Clin Lab Invest 1975;35:713-721.
23. Kaplan MM, Righetti A: Induction of rat liver alkaline phosphatase: the mechanism of the serum elevation in bile duct obstruction. J Clin Invest 1970;49:508-516.
24. Seetharam S, Sussman NL, Komoda T, et al: The mechanism of elevated alkaline activity after bile duct ligation in the rat. Hepatology 1986;6:374.
25. Brensilver HL, Kaplan MM: Significance of elevated liver alkaline phosphatase in serum. Gastroenterology 1975;68:1556-1562.
26. Hadjis NS, Blenkharn JI, Hatzis G, Adam A, Beacham J, Blumgart LH: Patterns of serum alkaline phosphatase activity in unilateral hepatic duct obstruction: A clinical and experimental study. Surgery 1990;107:193-200.
27. Klompje J, Petrelli NJ, Herrera L, Mittelman A: The prognostic value of preoperative alkaline phosphatase for resection of solitary liver metastasis from colorectal carcinoma. Eur J Surg Oncol 1987;13:345-347.
28. Osanaga E, Larre Borges A, Sanguinetti J, Mancusso G, Lopez A, Larreborges U: Comparative study between alkaline phosphatase and gamma-glutamyltranspeptidase in the diagnosis of hepatic metastases. J Chir 1992; 1985:17-20.
29. Karmen C, Mayne PD, Foo AY, Parbhoo S, Rosalki SB: Measurement of biliary alkaline phosphatase by mini-column chromatography and by electrophoresis and its application to the detection of liver metastases in patients with breast cancer. J Clin Pathol 1984;37:212-217.
30. Margolis R, Hansen HH, Muggia FM, Kanhouwa S: Diagnosis of liver metastases in bronchogenic carcinoma: A comparative study of liver scans, function tests, and peritoneoscopy with liver biopsy in 111 patients. Cancer 1974; 34:1825-1829.
31. Jonsson PE, Bengtsson G, Carlsson G, Jonson G, Tryding N: Value of serum-5-nucleotidase, alkaline phosphatase and gamma-glutamyl transferase for prediction of liver metastases preoperatively in colorectal cancer. Acta Chir Scand 1984;150:419-423.
32. Nishio H, Sakuma T, Nakamura S, Horai T, Ikegami H, Matsuda M: Diagnostic value of high molecular weight alkaline phosphatase in detection of hepatic metastasis in patients with lung cancer. Cancer 1986;57:1815-1819.
33. Christensen M, Jacobsen PM: Efficiency of composite tests in gastrointestinal cancer: Preoperative prediction of liver metastases by scintigraphy, alkaline phosphatase, and carcinoembryonic antigen. Scand J Gastroenterol 1987;22:273-278.
34. Lin HH, Lin DY: Is preoperative ultrasound cancer survey necessary in patients with normal liver function tests. J Clin Gastroenterol 1991;13:108-110.
35. Rocklin MS, Senagore AJ, Talbott TM: Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis Colon Rectum 1991;34:794-797.
36. Ottmar MD, Gonda RL Jr, Leithauser KJ, Gutierrez OH: Liver function tests in patients with computed tomography demonstrated hepatic metastases. Gastrointest Radiol 1989;14:55-58.
37. Rocklin MS, Slomski CA, Watne AL: Postoperative surveillance of patients with carcinoma of the colon and rectum. Am Surg 1990;56:22-27.
38. Schneider JF, Baker AL, Haines NW, Hatfield G, Boyer JL: Aminopyrine N-demethylation: A prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology 1980; 79:1145-1150.
39. Sahdew P, Meadow E, Garramone RR; Schwanz RJ, Steelman SR, Jacobs LM: Evaluation of liver function tests in screening for intra-abdominal injuries. Ann Emerg Med 1991;20:838-841.
40. Nagasue N, Yukaya H, Suehiro S, Ogawa Y: Tolerance of the cirrhotic liver to normothermic ischemia: A clinical study of 15 patients. Am J Surg 1984;147:772-775.
41. Lee YT: Liver function tests after ligation of hepatic artery. J Surg Oncol 1978;10:305-320.
42. Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T: Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer 1994;73:2464-2471.
43. Matsumata T, Higashi H, Shimada M, Adachi E, Shirabe K, Sugimachi K: Indications for major hepatectomy in cirrhotic liver. Hepatogastroenterology 1994;41:165-169.
44. Ratnoff OD: Disordered hemostasis in hepatic disease; in Schiff L, (ed): Diseases of the Liver. Philadelphia, Lippincott, 1975, pp 183-203.
45. Bontempo FA, Lewis JH, Van Thiel DH, et al: The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation 1985;39:532-536.
46. Ritter DM, Rettke SR, Lunn RJ, Bowie EJ, Ilstrup D: Preoperative coagulation screen does not predict intraoperative blood product requirements in orthotopic liver transplantation. Transplant Proc 1989;21:3533-3534.
47. Bengmark S, Zoukas E: Problems in haemostasis during liver surgery; in Bengmark S, Blumgart LH (ed): Liver Surgery. London, Churchill Livingstone, 1986, pp 156-165.
48. Tsuzuki T, Toyama K, Nakayasu K, Iida S, Ueda M, Toizumi A: Disseminated intravascular coagulation after hepatic resection. Surgery 1990;107:172-176.
49. Rondana M, Milani L, Merkel C, Caregaro L, Gatta A: Value of prealbumin plasma levels as liver test. Digestion 1987;37:72-78.
50. Andersson LO: Transport proteins. I. Serum albumin; in Blomback B, Hanson LA (eds): Plasma Proteins. Chichester, Wiley, 1976, pp 43-72.
51. Halliday AW, Benjamin IS, Blumgart LH: Nutritional risk factors in major hepatobiliary surgery. J Parenter Enterai Nutr 1988;12:43-48.
52. Reichen J: Assessment of hepatic function with xenobiotics. Semin Liver Dis 1995;15:189-201.
53. Oberhaensli R, Galloway G, Taylor D, Bore P, Radda G: Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br J Radiol 1986;59:695-699.
54. Angus PW, Dixon RM, Rajagopalan B, Ryley NG, Simpson KJ, Peters TJ, et al: A study of patients with alcoholic liver disease by 31P nuclear magnetic resonance spectroscopy. Clin Sci 1990;78:33-38.
55. Dufour J, Stoupis C, Lazeyras F, Vock P, Terrier F, Reichen J: Alterations in hepatic fructose metabolism in cirrhotic patients demonstrated by dynamic 31-phosphorus spectroscopy. Hepatology 1992;15:835-842.
56. Reichen J, Widmer T, Cotting J: Accurate prediction of death by serial determination of the galactose elimination capacity in primary biliary cirrhosis: A comparison with the Mayo model. Hepatology 1991;14:504-510.
57. Zoli M, Marchesini G, Melli A, Viti G, Marra A, Marrano D, et al: Evaluation of liver volume and liver function following hepatic resection in man. Liver 1986;6:286-291.
58. Asano M, Ozawa K, Tobe T: Postoperative prognosis as related to blood ketone body ratios in hepatectomized patients. Eur Surg Res 1983; 15:302-311.
59. Ueda J, Mori K, Sakai Y, Tanaka A, Katayama T, Maki A, et al: Noninvasive evaluation of cytochrome c oxidase activity of the liver: Its prognostic value for hepatic resection. Arch Surg 1994;129:303-308.
60. Mori K, Ozawa K, Yamamoto Y, Maki A, Shimahara Y, Kobayashi N, et al: Response of hepatic mitochondrial redox state to oral glucose load: Redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990:211:438-446.
61. Merkel C, Bolognesi M, Bellon S, Honisch B, Lampe H, Angeli P, et al: Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis. Gut 1992;33:836-842.
62. Villeneuve JP, Infante Rivard C, Ampelas M, Pomier-Layrargues G, Huet PM, Marleau D: Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986;6:928-931.
63. Gill RA, Goodman MW, Golfus GR, Onstad GR, Bubrick MP: Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 1983;198:701-704.
64. Horsmans Y, Lejeune D, Geubel AP, Otte JB, Pauwels S: Hepatic [C-14]aminopyrine demethylation capacity after portocaval shunting: Comparative study in patients with and without arterialization of portal vein. Dig Dis Sci 1993;38:2177-2182.
65. McPherson GAD, Benjamin IS, Boobis AR, Brodie MJ, Hampden C, Blumgart LH: Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice. Gut 1982;23:734-738.
66. Lee CS, Chao CC, Lin TY: Partial hepatectomy on cirrhotic liver with a right lateral tumor. Surgery 1985;98:942-948.
67. Moody FG, Rikkers LF, Aldrette JS: Estimation of the functional reserve of human liver. Ann Surg 1974;180:592-599.
68. Noguchi T, Imai T, Mizumoto R: Preoperative estimation of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology 1990;37:165-171.
69. Speich R, Saesseli B, Hoffmann U, Neftel K, Reichen J: Anaphylactoid reactions after indocyanine-green administration. Ann Intern Med 1988;109:345-346.
70. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR: Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163:515-518.
71. Matsumata T, Kanematsu T, Yoshida Y, Furuta T, Yanaga K, Sugimachi K: The indocyanine green test enables prediction of postoperative complications after hepatic resection. World J Surg 1987;11:678-681.
72. Hasegawa H, Yamazaki S, Makuuchi M, Elias D: Hepatectomy for hepatocarcinoma on a cirrhotic liver: decision plans and principles of perioperative resuscitation: Experience with 204 cases. J Chir 1987;124:425-431.
73. Yamanaka N, Okamoto E, Kuwata K, Tanaka N: A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg 1984;200:658-663.
74. Oellerich M, Ringe B, Gubernatis G, Pichlmayr R, Burdelski M, Lamesch P, Bunzendahl H, Herrmann H: Lignocaine metabolite formation as a measure of pre-transplant liver function. Lancet 1989;i:640-642.
75. Oellerich M, Burdelski M, Lautz HU, Binder L, Pichlmayr R: Predictors of one-year pretransplant survival in patients with cirrhosis. Hepatology 1991;14:1029-1034.
76. Reichen J: MEGX test in hepatology: The longsought, ultimate quantitative liver function test? J Hepatol 1993;19:4-7.
77. Child CG, Turcotte JG: Surgery and portal hypertension; in Child CG (ed): The Liver and Portal Hpyertension. Philadelphia, Saunders, 1964, pp 50-62.
78. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transsection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
79. Conn HO: A peek at the Child-Turcotte classification. Hepatology 1981;1:673-676.
80. Sue B, Panis Y, Belghiti J, Fekete F: 'Natural history' of hepatectomy. Br J Surg 1992;79:39-42.
81. Franco D, Capussotti L, Smadja C, Bouzari H, Meakins J, Kemeny F, et al: Resection of hepatocellular carcinomas: Results in 72 European patients with cirrhosis. Gastroenterology 1990; 98:733-738.
82. Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, et al: Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:28-34.
83. Yanaga K, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K: Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988;155:238-241.
84. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer 1985;56:918-928.
85. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, et al: Prognostic factors of hepatocellular carcinoma in the West: A multivariate analysis in 206 patients. Hepatology 1990; 12: 753-760.
86. Yamanaka N, Okamoto E, Oriyama T, Fujimoto J, Furukawa K, Kawamura E, et al: A prediction scoring system to select the surgical treatment of liver cancer Further refinement based on 10 years of use. Ann Surg 1994;219: 342-346.
87. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K, et al: Estimation of risk of major complications after hepatic resection. Am J Surg 1994;167:399-403.
88. Bismuth H, Houssin D, Mazmanian G: Postoperative liver insufficiency: Prevention and management. World J Surg 1983;7:505-510.
89. Okamoto E, Kyo A, Yamanaka N, Tanaka N, Kuwata K: Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function. Surgery 1984;95:586-592.
90. Takenaka K, Kanematsu T, Fukuzawa K, Sugimachi K: Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg 1990;14:123-127.
91. Sugarbaker PH: Surgical decision making for large bowel cancer metastatic to the liver. Radiology 1990;174:621-626.
92. Soyer P, Roche A, Elias D, Levesque M: Hepatic metastases from colorectal cancer: Influence of hepatic volumetric analysis on surgical decision making. Radiology 1992;184:695-697.
93. Lin TY, Chen CC: Metabolic function and regeneration of cirrhotic and non-cirrhotic livers after hepatic lobectomy in man. Ann Surg 1965;162:959-972.
94. Lin TY, Lee CS, Chen CC, Liau KY, Lin WS: Regeneration of human liver after hepatic lobectomy studied by repeated liver scanning and repeated needle biopsy. Ann Surg 1979; 190:48-53.
95. Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T: Human liver regeneration after major hepatic resection: A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg 1987;206:30-39.
96. MacIntosh EL, Minuk GY: Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 1992;174: 245-254.
97. Yamanaka N, Okamoto E, Kawamura E, Kato T, Oriyama T, Fujimoto J, et al: Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 1993;18:79-85.
98. Zucker MB, Siegel M, Cliffton EE, Belleville JW, Howland WS, Grossi CE: The effect of hepatic lobectomy on some blood clotting factors and on fibrinolysis. Ann Surg 1957;146: 772-781.
99. Almersjo O, Bengmark S, Hafstrom LO, Olsson R: Enzyme and function changes after extensive liver resection in man. Ann Surg 1969;169:111-119.
100. Pinkerton JA, Sawyers JL, Foster JH: A study of the postoperative course after hepatic lobectomy. Ann Surg 1971;173:800-811.
101. Bolder U, Tacke J, Imhoff M, Lohlein D: Postoperative course of functional and cellular variables in liver resection. Scand J Gastroenterol 1993;28:949-957.
102. Elias D, Desruennes E, Lasser P: Prolonged intermittent clamping of the portal triad during hepatectomy. Br J Surg 1991;78:42-44.
103. Delva E, Camus Y, Nordlinger B, Hannoun L, Parc R, Deriaz H, et al: Vascular occlusions for liver resections: Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989;209:211-218.